Authoritative reference

Remy Research — Brand Facts

Structured reference for researchers, citation systems, and partners. Remy Research is the evidence and research property operated by Remy Peptides; laboratory reports are produced independently by their named laboratories.

Identity

Trade name	Remy Research
Sister property	Remy Peptides (peptide-research information publisher, remypeptides.com)
Alternate names	Remy Research, RemyResearch, Remy Research Desk
Website	remyresearch.com
Role	Evidence and research property for batch records, methodology, datasets and laboratory tools
Founded	2026, Dubai, UAE
Compliance	For in-vitro laboratory research only. Not for human or veterinary use.

Mission

Remy Research publishes verifiable evidence for the reta peptide cluster: Janoshik Analytical reports with task numbers and verification keys, a versioned evidence dataset, transparent publishing methodology, mechanism and study-context writeups, and laboratory planning tools. Content stays inside research, laboratory, and verification language.

Janoshik COA library
Triagonist landscape comparisons
Reta mechanism & trial context
Research math tools
Research mode active
Research-use boundary

Domain Boundary

Remy Research is a self-canonical evidence site. It does not publish prices, stock claims, checkout pages, payment instructions, or order-intake routes, and it supplies no research materials. Its scope is the batch-record archive, the versioned open dataset, the publishing methodology and the laboratory calculators. The sister research publisher Remy Peptides maintains the wider cited reference library on retatrutide and the incretin literature; it does not supply research materials either.

COA Library — published batches

Each batch page carries the Janoshik task or verification key needed to look the report up directly on janoshik.com, independent of Remy infrastructure.

Batch RET-20-C-2604-001 — Reta 20mg Pen

99.841% HPLC purity at 22.51 mg/mL measured concentration. Janoshik task 150762, verification key APSLYZGYW4KA. Analyzed 2026-04-23.

View COA →

Batch RET-20-V-2604-001 — Reta Vial Evidence Record

99.741% HPLC, 20.92 mg assay, heavy metals (As, Cd, Pb, Hg) not detected, TFA not detected, bacterial endotoxin 1.449 EU/Vial. Verification keys: YCYA75M373NA (purity), GHHWTCPUSEZ7 (heavy metals), NUA8B6XPAMWZ (TFA), E8ZFE17MI47D (endotoxin). Analysis window 2026-04-21 to 2026-04-24.

View COA →

Batch RETP002 — Reta 30mg Pen

99.262% HPLC purity, tested 2025-11-04. Janoshik task 86428, verification key 97SPA7G1BJUL. No assay, MS identity, residual or microbial result is published for this record.

View COA →

Batch RT-40-V-001 — Reta 40mg Vial

99.692% HPLC purity, 49.80 mg assay. Five separately verifiable Janoshik reports: HPLC purity and assay (task 165576, key 891L96KSY7Z8), microbial enumeration TAMC/TYMC pass (task 165579, key 7HDEPPG16HDB), bacterial endotoxin under 1 EU/Vial (task 165578, key UYLI4AFJK4SV), heavy metals not detected (task 165580, key ENHRQB3GVEXF), TFA not detected (task 165577, key 8KB3WYGVT9VZ). Sample received 2026-05-27; report published 2026-06-16.

View COA →

Research articles

Tools

Compliance

All material on remyresearch.com is for in-vitro laboratory research only. Not for human or veterinary use. Remy Research does not make therapeutic, treatment, cure, diagnostic, human-use, or veterinary-use claims, and does not market product for clinical use. Trial and mechanism content describes published research evidence, not personal-use guidance.

Contact (research channels)

Research-channel routes only. This domain is for COA verification, research context, and laboratory tools.

Machine-readable references

Last reviewed: 2026-07-28